These ‘master’ proteins protect us from deadly mutations — and could inspire new drugs
By Philip Ball,
Nature
| 06. 17. 2026
Our genomes are full of mutations that have the potential to damage our health or even kill us. Yet most of them rarely cause problems. Why? It’s partly thanks to a family of proteins that mask, or ‘buffer’, the ill effects that these mutations would otherwise unleash. This buffering might help to explain why gene variants cause disease in some people but seem to have limited or no impact on others. It could also underlie how some cancer cells and pathogens threaten their hosts and evade drugs. And it enables genetic variation to accumulate in populations, providing a potential resource for future evolution.
Researchers have known for decades that one of the most important factors in mutational buffering is a protein called HSP90 and its family of other HSP proteins. Now, biologists are examining the roles of these proteins in more detail than they ever could before, owing to advances in techniques such as cell screening and genetic editing, as well as the availability of large genomic data sets and extensive health records.
Advances in the past two decades or...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...